Ticker
CLSDCompany Name
CLEARSIDE BIOMEDICAL INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -21.73M | -1616.52% | $ 1.34M |
3/31/2025 | $ -22.68M | -1581.38% | $ 1.43M |
12/31/2024 | $ -24.7M | -1484.25% | $ 1.66M |
9/30/2024 | $ -18.95M | -246% | $ 7.7M |
6/30/2024 | $ -19.11M | -254% | $ 7.52M |
3/31/2024 | $ -18.77M | -222.08% | $ 8.45M |
12/31/2023 | $ -18.14M | -220.46% | $ 8.23M |
9/30/2023 | $ -24.24M | -1096.2% | $ 2.21M |
6/30/2023 | $ -24.35M | -1504.82% | $ 1.62M |
3/31/2023 | $ -24.45M | -2484.96% | $ 984K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for CLEARSIDE BIOMEDICAL INC is calculated as follows: CF - Operations [ $ -7M ] / Revenues [ $ 9.82M ]
(=) OCF % [ -71.2% ]
Minimum
Mar 31, 2023
Maximum
Jun 30, 2022
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 78.12% |
average | 14.35% |
median | 12.67% |
std | 21.14% |